"PanTera to Establish Pioneering Actinium Production Center for Cancer Treatment in Belgium"

"Stibbe's projects practice has assisted PanTera in developing its Actinium Production Center (APC), which will produce Actinium-225, an important isotope for cancer treatment. PanTera, a joint venture between IBA and SCK CEN, has secured the necessary permits to begin construction, with the facility expected to be operational by 2028 and commercial supply starting in 2029. The APC aims to establish a reliable global supply of Ac-225, positioning Belgium as a leader in nuclear medicine and contributing significantly to cancer treatment efforts."

Stibbe, a prominent law firm, assisted PanTera, a joint venture between IBA and SCK CEN, in the development of its Actinium Production Center (APC), a groundbreaking facility for the large-scale production of Actinium-225 (Ac-225), an essential isotope for targeted alpha therapy in cancer treatment. The transaction involved securing all necessary nuclear and environmental permits for the construction of the APC, which is set to become operational in 2028, with commercial supply anticipated in 2029. The facility will significantly enhance the global supply of Ac-225, positioning Belgium as a leader in nuclear medicine innovation and contributing to the global fight against cancer. The Stibbe team that participated in this transaction included Rony Vermeersch, Anneleen Quirynen, Elmo Goossens, and Lucie Monfils. The press release does not specify their seniority or practice areas.

"PanTera to Establish Pioneering Actinium Production Center for Cancer Treatment in Belgium"

Read the full story

Cookie Preferences

Strictly Necessary

Analytics & Statistics

Marketing & Ads